Ebola treatments trial begins in the Democratic Republic of Congo
Summary
A clinical trial has started in the Democratic Republic of Congo (DRC) to test new treatments for the current Ebola outbreak caused by the Bundibugyo virus. The World Health Organization (WHO) announced that the first patient has been enrolled in the trial, which aims to find safe and effective therapies to reduce deaths from the disease.Key Facts
- The Ebola outbreak began in May and affects the DRC and Uganda, with some cases reported in France.
- More than 1,400 confirmed cases and 438 deaths have been reported in the DRC as of late June.
- The trial tests two new treatments and is led by WHO in cooperation with research institutes in DRC, Belgium, and the UK.
- Bundibugyo virus is a strain of Ebola with no approved vaccines or treatments currently.
- Ebola is a virus that harms the immune system and organs, passed from animals like fruit bats to humans.
- People usually spread the disease only after showing symptoms, which appear 2 to 21 days after infection.
- Symptoms begin suddenly and resemble flu or malaria, including fever, headache, and tiredness.
- The WHO declared the outbreak a public health emergency to highlight its seriousness.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
